The role of leptin in non-alcoholic fatty liver disease | Zendy

RedaA Elbadawy | Zendy; EmanA Eleter | Zendy; Ahmed Helmy | Zendy; AbdallaS Al Ghamdi | Zendy; Ibrahim A. Al-Mofleh | Zendy; FalehZ Al Faleh | Zendy; Hussain Al Freihi | Zendy; Saleh M Al-Amri | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The role of leptin in non-alcoholic fatty liver disease

Author(s) -

RedaA Elbadawy,

EmanA Eleter,

Ahmed Helmy,

AbdallaS Al Ghamdi,

Ibrahim A. Al-Mofleh,

FalehZ Al Faleh,

Hussain Al Freihi,

Saleh M Al-Amri

Publication year - 2006

Publication title -

saudi journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.608

H-Index - 32

eISSN - 1998-4049

pISSN - 1319-3767

DOI - 10.4103/1319-3767.27848

Subject(s) - medicine , leptin , steatohepatitis , steatosis , fatty liver , cirrhosis , gastroenterology , fibrosis , chronic liver disease , pathogenesis , histopathology , disease , obesity , pathology

The role of steatosis in the pathogenesis of chronic liver disease (CLD) is now believed to form part of a continuum in non-alcoholic fatty liver disease (NAFLD). One of the unconventional areas in which leptin is now receiving great attention is liver diseases. Several published studies indicate that circulating leptin is increased in patients with cirrhosis, chronic HCV, and non-alcoholic steatohepatitis (NASH).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research